Urology · Springfield, OR
NPI
1063572238
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2400 Hartman Ln
Springfield, OR, 97477
Phone (541) 334-3350
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
6,140 services
Medicare patients, 2024
497
Average age 75
Drug cost, 2024
$2.4M
1,494 prescriptions
Company payments, 2025
$546
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey B Woolsey was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 3,107 times for 29 patients. In total Jeffrey B Woolsey billed 6,140 services in 79 codes, and Medicare paid $135K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,107 | 29 | $0.10 | $309 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 284 | 229 | $11.24 | $3,191 |
| 99214 Office E&M - Established | Office | 239 | 188 | $80.39 | $19K |
| 51798 Ultrasound - Nonspecific | Office | 205 | 188 | $7.43 | $1,523 |
| 81002 Clinical Chemistry | Office | 182 | 163 | $3.40 | $618 |
| 99213 Office E&M - Established | Office | 134 | 111 | $55.04 | $7,375 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 102 | 12 | $139.96 | $14K |
| 52000 Cystourethroscopy | Facility | 75 | 65 | $58.88 | $4,416 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 67 | 43 | $49.33 | $3,305 |
| 99204 Office E&M - New | Office | 67 | 67 | $99.81 | $6,687 |
| 52000 Cystourethroscopy | Office | 39 | 33 | $154.67 | $6,032 |
| 74420 Standard X-ray | Facility | 34 | 24 | $18.49 | $629 |
| 81000 Clinical Chemistry | Office | 34 | 33 | $3.82 | $130 |
| 76872 Ultrasound - Nonspecific | Facility | 28 | 27 | $23.84 | $668 |
| 55700 Other Organ Systems | Facility | 27 | 26 | $88.29 | $2,384 |
By year: 2022 $139K for 5,736 services; 2023 $119K for 4,742 services; 2024 $135K for 6,140 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 182 | 163 | $3.40 | $618 |
| 81000 Clinical Chemistry | 34 | 33 | $3.82 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey B Woolsey prescribed most often to Medicare patients was Finasteride, with 308 prescriptions and refills. In total Jeffrey B Woolsey wrote 1,494 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 308 | 842 | 94 | $4,694 |
| Tamsulosin Hcl Generic | 302 | 866 | 110 | $5,607 |
| Dutasteride Generic | 144 | 423 | 51 | $5,211 |
| Orgovyx Relugolix | 93 | 93 | 13 | $245K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 84 | 98 | 75 | $348 |
| Oxycodone Hcl Generic | 61 | 61 | 57 | $168 |
| Prednisone Generic | 58 | 58 | Under 11 | $361 |
| Erleada Apalutamide | 50 | 50 | Under 11 | $733K |
| Abiraterone Acetate Generic | 44 | 44 | Under 11 | $37K |
| Xtandi Enzalutamide | 43 | 43 | Under 11 | $587K |
| Nubeqa Darolutamide | 31 | 31 | Under 11 | $410K |
| Yonsa Abiraterone Acet,submicronized | 30 | 30 | Under 11 | $308K |
| Cephalexin Generic | 26 | 48 | 16 | $241 |
| Gemtesa Vibegron | 23 | 59 | Under 11 | $28K |
| Myrbetriq Mirabegron | 19 | 31 | Under 11 | $13K |
Brand drugs: 295 claims; generic drugs: 1,199 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey B Woolsey $546 ($546 in general payments such as food, travel and fees) from 9 companies. The largest payer was Procept Biorobotics Corporation with $195.
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation PRCT | 2 | $195 |
| Ferring Pharmaceuticals Inc. | 5 | $117 |
| Caris MPI, Inc. | 2 | $57.05 |
| Janssen Biotech, Inc. JNJ | 2 | $39.99 |
| Tolmar, Inc. | 1 | $34.91 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $31.05 |
| Dendreon Pharmaceuticals LLC | 1 | $30.71 |
| Valencia Technologies Corporation | 1 | $20.36 |
| Pfizer Inc. PFE | 1 | $19.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.